> Details

Bailey, Peter; Ridgway, Rachel A.; Cammareri, Patrizia; Treanor-Taylor, Mairi; Bailey, Ulla-Maja; Schoenherr, Christina; Bone, Max; Schreyer, Daniel; Purdie, Karin; Thomson, Jason; Rickaby, William; Jackstadt, Rene; Campbell, Andrew D.; Dimonitsas, Emmanouil; Stratigos, Alexander J.; Arron, Sarah T.; Wang, Jun; Blyth, Karen; Proby, Charlotte M.; Harwood, Catherine A.; Sansom, Owen J.; Leigh, Irene M.; Inman, Gareth J.

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression
  • Contributor: Bailey, Peter; Ridgway, Rachel A.; Cammareri, Patrizia; Treanor-Taylor, Mairi; Bailey, Ulla-Maja; Schoenherr, Christina; Bone, Max; Schreyer, Daniel; Purdie, Karin; Thomson, Jason; Rickaby, William; Jackstadt, Rene; Campbell, Andrew D.; Dimonitsas, Emmanouil; Stratigos, Alexander J.; Arron, Sarah T.; Wang, Jun; Blyth, Karen; Proby, Charlotte M.; Harwood, Catherine A.; Sansom, Owen J.; Leigh, Irene M.; Inman, Gareth J.
  • Published: Springer Science and Business Media LLC, 2023
  • Published in: Nature Communications, 14 (2023) 1
  • Language: English
  • DOI: 10.1038/s41467-023-40822-9
  • ISSN: 2041-1723
  • Origination:
  • Footnote:
  • Description: AbstractThe molecular basis of disease progression from UV-induced precancerous actinic keratosis (AK) to malignant invasive cutaneous squamous cell carcinoma (cSCC) and potentially lethal metastatic disease remains unclear. DNA sequencing studies have revealed a massive mutational burden but have yet to illuminate mechanisms of disease progression. Here we perform RNAseq transcriptomic profiling of 110 patient samples representing normal sun-exposed skin, AK, primary and metastatic cSCC and reveal a disease continuum from a differentiated to a progenitor-like state. This is accompanied by the orchestrated suppression of master regulators of epidermal differentiation, dynamic modulation of the epidermal differentiation complex, remodelling of the immune landscape and an increase in the preponderance of tumour specific keratinocytes. Comparative systems analysis of human cSCC coupled with the generation of genetically engineered murine models reveal that combinatorial sequential inactivation of the tumour suppressor genesTgfbr2,Trp53, andNotch1coupled with activation of Ras signalling progressively drives cSCC progression along a differentiated to progenitor axis. Taken together we provide a comprehensive map of the cSCC disease continuum and reveal potentially actionable events that promote and accompany disease progression.
  • Access State: Open Access